• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:薛晶,黄宝斌,仲宣惟,王杉.药品医疗器械化妆品复验/复检程序对比[J].药学研究,2026,45(7):830-833,840[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 949次   下载 575次 本文二维码信息
码上扫一扫!
药品医疗器械化妆品复验/复检程序对比
薛晶,黄宝斌,仲宣惟,王杉
字体:加大+|默认|缩小-
(中国药品检定研究院,北京 102629)
摘要:
本文系统比较了药品、医疗器械、化妆品在复验/复检程序上的法规异同。研究发现,现行法规在受理机构、检验时限等核心环节规定上存在不一致;同时面临样品封签管理不统一、报告送达时限执行不一致、电子检验报告法律效力未明确、多方重复申请问题突出、复验/复检机构独立性规定不一致、无法受理时缺乏终止机制等共性问题,影响了救济效率与公正性。建议构建规范一致的程序框架,明确电子报告法律效力,统一送达认定标准与多方申请规则,探索复验/复检与异议区别处理,并健全沟通机制与信息平台建设,以提升监管公信力与申请人权利保障水平。
关键词:  药品  医疗器械  化妆品  复验程序  复检程序
DOI:10.13506/j.cnki.jpr.2026.07.017
基金项目:
收稿日期:2026-04-20   修回日期:2026-05-18   出版日期:2026-07-31
Comparison study for the re-inspection/re-examination procedures of drugs, medical devices, and cosmetics
XUE Jing,HUANG Baobin,ZHONG Weixuan,WANG Shan
(National Institutes for Food and Drug Control, Beijing 102629, China)
Abstract:
A systematic comparison was conducted on the regulatory similarities and differences in the re-inspection/re-examination procedures among drugs, medical devices, and cosmetics. It was found that inconsistencies existed in the current regulations regarding core procedures such as the accepting institutions and inspection time limits. Meanwhile, common problems were identified, including non-unified sample sealing management, inconsistent implementation of report delivery time limits, unclear legal validity of electronic inspection reports, prominent issues of duplicate applications by multiple parties, inconsistent provisions on the independence of re-inspection/re-examination institutions, and the lack of termination mechanisms when applications could not be accepted, all of which affected the efficiency and impartiality of the remedy process. To enhance regulatory credibility and the protection of applicants' rights, it was suggested that a standardized and consistent procedural framework should be established, the legal validity of electronic reports should be clarified, unified standards for delivery confirmation and multi-party application rules should be established, differentiated treatment of re-inspection/re-examination and objections should be explored, and communication mechanisms and information platform construction should be improved.
Key words:  Drugs  Medical devices  Cosmetics  Re-inspection procedure  Re-examination procedure
今日访问量:2274    总访问量:55338616
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司